Login / Signup

The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial.

Mei-Jyh ChenChieh-Chang ChenYu-Chun HuangChieh-Chih TsengJing-Ting HsuYi-Fen LinYu-Jen FangMing-Shiang WuJyh-Ming Liounull null
Published in: Helicobacter (2021)
Although the use of Lactobacillus acidophilus and Lactobacillus rhamnosus may reduce the bacterial load of H. pylori, there were no significant changes in the composition of gut microbiota. This trial is registered with ClinicalTrials.gov, NCT02725138.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • phase iii
  • placebo controlled
  • study protocol
  • phase ii
  • lactic acid
  • double blind
  • clinical trial
  • squamous cell carcinoma
  • open label